These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 2746475)

  • 1. Iontophoretic delivery of model inorganic and drug ions.
    Phipps JB; Padmanabhan RV; Lattin GA
    J Pharm Sci; 1989 May; 78(5):365-9. PubMed ID: 2746475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Electronic control of iontophoretic drug delivery.
    Lattin GA; Padmanabhan RV; Phipps JB
    Ann N Y Acad Sci; 1991; 618():450-64. PubMed ID: 1706579
    [No Abstract]   [Full Text] [Related]  

  • 3. Combined effects of iontophoretic and chemical enhancement on drug delivery. II. Transport across human and murine skin.
    Nolan LM; Corish J; Corrigan OI; Fitzpatrick D
    Int J Pharm; 2007 Aug; 341(1-2):114-24. PubMed ID: 17502130
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contributions of electromigration and electroosmosis to iontophoretic drug delivery.
    Marro D; Kalia YN; Delgado-Charro MB; Guy RH
    Pharm Res; 2001 Dec; 18(12):1701-8. PubMed ID: 11785689
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Current profile controlled transdermal delivery of pramipexole from an iontophoretic patch system in vitro and in vivo.
    Singhal M; Serna C; Merino V; Kalia YN
    Eur J Pharm Biopharm; 2021 Sep; 166():175-181. PubMed ID: 34175373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of conductivity in iontophoresis. 2. Anodal iontophoretic transport of phenylethylamine and sodium across excised human skin.
    Yoshida NH; Roberts MS
    J Pharm Sci; 1994 Mar; 83(3):344-50. PubMed ID: 8207679
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transport numbers in transdermal iontophoresis.
    Mudry B; Guy RH; Delgado-Charro MB
    Biophys J; 2006 Apr; 90(8):2822-30. PubMed ID: 16443654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Optimizing iontophoretic drug delivery: identification and distribution of the charge-carrying species.
    Marro D; Kalia YN; Delgado-Charro MB; Guy RH
    Pharm Res; 2001 Dec; 18(12):1709-13. PubMed ID: 11785690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iontophoretic drug delivery.
    Kalia YN; Naik A; Garrison J; Guy RH
    Adv Drug Deliv Rev; 2004 Mar; 56(5):619-58. PubMed ID: 15019750
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Controlled iontophoretic delivery of pramipexole: electrotransport kinetics in vitro and in vivo.
    Kalaria DR; Patel P; Merino V; Patravale VB; Kalia YN
    Eur J Pharm Biopharm; 2014 Sep; 88(1):56-63. PubMed ID: 24525072
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Compartmental modeling of transdermal iontophoretic transport II: in vivo model derivation and application.
    Nugroho AK; Della-Pasqua O; Danhof M; Bouwstra JA
    Pharm Res; 2005 Mar; 22(3):335-46. PubMed ID: 15835738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. To enhance the efficiency of nefopam transdermal iontophoresis by using a novel method based on ion-exchange fiber.
    Xin C; Lihong W; Fei H; Yan W; Qifang W; Yang Y; Yue Y; San-ming L
    Drug Dev Ind Pharm; 2014 Jan; 40(1):9-16. PubMed ID: 23317337
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Iontophoretic transport kinetics of ketorolac in vitro and in vivo: demonstrating local enhanced topical drug delivery to muscle.
    Gratieri T; Pujol-Bello E; Gelfuso GM; de Souza JG; Lopez RF; Kalia YN
    Eur J Pharm Biopharm; 2014 Feb; 86(2):219-26. PubMed ID: 23791718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Influence of constant current iontophoresis on the impedance and passive Na+ permeability of excised nude mouse skin.
    Burnette RR; Bagniefski TM
    J Pharm Sci; 1988 Jun; 77(6):492-7. PubMed ID: 3171927
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Electromigration of ions across the skin: determination and prediction of transport numbers.
    Mudry B; Guy RH; Delgado-Charro MB
    J Pharm Sci; 2006 Mar; 95(3):561-9. PubMed ID: 16419050
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Trans-scleral iontophoretic delivery of low molecular weight therapeutics.
    Güngör S; Delgado-Charro MB; Ruiz-Perez B; Schubert W; Isom P; Moslemy P; Patane MA; Guy RH
    J Control Release; 2010 Oct; 147(2):225-31. PubMed ID: 20655965
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of formulation factors on the trans-scleral iontophoretic and post-iontophoretic transports of a 40 kDa dextran in vitro.
    Pescina S; Padula C; Santi P; Nicoli S
    Eur J Pharm Sci; 2011 Apr; 42(5):503-8. PubMed ID: 21352911
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transdermal iontophoretic drug delivery: advances and challenges.
    Ita K
    J Drug Target; 2016; 24(5):386-91. PubMed ID: 26406291
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Controlled iontophoretic transport of huperzine A across skin in vitro and in vivo: effect of delivery conditions and comparison of pharmacokinetic models.
    Kalaria DR; Patel P; Merino V; Patravale VB; Kalia YN
    Mol Pharm; 2013 Nov; 10(11):4322-9. PubMed ID: 24028565
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Using transdermal iontophoresis to increase granisetron delivery across skin in vitro and in vivo: effect of experimental conditions and a comparison with other enhancement strategies.
    Cázares-Delgadillo J; Ganem-Rondero A; Quintanar-Guerrero D; López-Castellano AC; Merino V; Kalia YN
    Eur J Pharm Sci; 2010 Mar; 39(5):387-93. PubMed ID: 20096354
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.